Matt Phipps
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
14
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TENX Tenax Therapeutics | Initiates: Outperform | n/a | $4.47 | - | 1 | Sep 30, 2024 | |
| CGEM Cullinan Therapeutics | Initiates: Outperform | n/a | $15.92 | - | 1 | Apr 15, 2024 | |
| BMY Bristol-Myers Squibb Company | Downgrades: Market Perform | n/a | $55.45 | - | 1 | Oct 27, 2023 | |
| KZR Kezar Life Sciences | Downgrades: Market Perform | n/a | $7.09 | - | 2 | Mar 16, 2023 | |
| JANX Janux Therapeutics | Initiates: Outperform | n/a | $55.87 | - | 1 | Nov 14, 2022 | |
| GMAB Genmab | Initiates: Market Perform | n/a | $22.78 | - | 1 | Nov 14, 2022 | |
| ALRN Aileron Therapeutics | Downgrades: Market Perform | n/a | $4.00 | - | 1 | Jun 29, 2022 | |
| INKT MiNK Therapeutics | Initiates: Outperform | n/a | $0.73 | - | 1 | Nov 9, 2021 | |
| TPST Tempest Therapeutics | Initiates: Outperform | n/a | $0.94 | - | 1 | Oct 21, 2021 | |
| JSPR Jasper Therapeutics | Initiates: Outperform | n/a | $22.03 | - | 1 | Oct 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $173.52 | - | 2 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $51.23 | - | 1 | Apr 8, 2021 |
Tenax Therapeutics
Sep 30, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.47
Upside: -
Cullinan Therapeutics
Apr 15, 2024
Initiates: Outperform
Price Target: n/a
Current: $15.92
Upside: -
Bristol-Myers Squibb Company
Oct 27, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $55.45
Upside: -
Kezar Life Sciences
Mar 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.09
Upside: -
Janux Therapeutics
Nov 14, 2022
Initiates: Outperform
Price Target: n/a
Current: $55.87
Upside: -
Genmab
Nov 14, 2022
Initiates: Market Perform
Price Target: n/a
Current: $22.78
Upside: -
Aileron Therapeutics
Jun 29, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $4.00
Upside: -
MiNK Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.73
Upside: -
Tempest Therapeutics
Oct 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.94
Upside: -
Jasper Therapeutics
Oct 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $22.03
Upside: -
Jun 8, 2021
Upgrades: Outperform
Price Target: n/a
Current: $173.52
Upside: -
Apr 8, 2021
Initiates: Outperform
Price Target: n/a
Current: $51.23
Upside: -